RYTM

RHYTHM PHARMACEUTICALS, INC.

Biotechnology · Biotechnology

$50.76 sample

-0.75 (-1.46%) 1D

Market cap

$319.4B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-04

Alerts

8

Price$50.76 +6.68% 3M daily closessample

51.5147.41

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29INSInsider buy: General Counsel
Sep 23INSInsider sell: General Counsel
Sep 17INSInsider buy: EVP, Operations
Sep 14INSInsider buy: Chief Financial Officer
Sep 04SEC10-Q filed
Aug 31INSInsider sell: EVP, Operations
Aug 24INSInsider sell: General Counsel
Aug 17INSInsider sell: EVP, Operations

Sign up to see the real RYTM record →

Company facts

SEC EDGAR registration

Name: RHYTHM PHARMACEUTICALS, INC.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -10sample, -100 to +100
Reporting currency: USD

Who is positioning in RYTM

sample

Insiders: 21 insider transactions over 90 days, net selling, $340.0M
Congress: 4 members traded over 90 days
Institutions · 13F: 25 funds hold $1.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$15.2B +12.9% y/y

Q4 2024Q3 2026

Inventory$9.5B +13.6% y/y

Q4 2024Q3 2026

Accounts receivable$6.6B +6.3% y/y

Q4 2024Q3 2026

Total debt$17.9B +7.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $275.2B +4.8% 3M
Sample peer B: $266.9B +11.1% 3M
Sample peer C: $190.1B -9.3% 3M
Sample peer D: $120.6B +16.4% 3M
Sample peer E: $100.4B +14.6% 3M